Literature DB >> 19444967

Protective effects of a carbon monoxide-releasing molecule (CORM-3) during hepatic cold preservation.

M D Pizarro1, J V Rodriguez, M E Mamprin, B J Fuller, B E Mann, R Motterlini, E E Guibert.   

Abstract

UNLABELLED: There is increasing evidence that carbon monoxide (CO), a signaling molecule generated during the degradation of heme by heme oxygenase-1 (HO-1) in biological systems, has a variety of cytoprotective actions, including anti-hypoxic effects at low temperatures. However, during liver cold preservation, a direct effect needs to be established. Here, we designed a study to analyze the role of CO, delivered via a carbon monoxide-releasing molecule (CO-RM) in the maintenance of liver function, and integrity in rats during cold ischemia/reperfusion (CI/R) injury. We used an isolated normothermic perfused liver system (INPL) following a clinically relevant model of ex vivo 48 h cold ischemia stored in a modified University of Wisconsin (UW) solution, to determine the specific effects of CO in a rat model. CO was generated from 50 microM tricarbonylchloro ruthenium-glycinato (CORM-3), a water-soluble transition metal carbonyl that exerts pharmacological activities via the liberation of controlled amounts of CO in biological systems. The physiological effects of CORM-3 were confirmed by the parallel use of a specific inactive compound (iCORM-3), which does not liberate CO in the cellular environment. CORM-3 addition was found to prevent the injury caused by cold storage by improving significantly the perfusion flow during reperfusion (by almost 90%), and by decreasing the intrahepatic resistance (by 88%) when compared with livers cold preserved in UW alone. Also, CORM-3 supplementation preserved good metabolic capacity as indicated by hepatic oxygen consumption, glycogen content, and release of lactate dehydrogenase. Liver histology was also partially preserved by CORM-3 treatment.
CONCLUSIONS: These findings suggest that CO-RM could be utilized as adjuvant therapeutics in UW solutions to limit the injury sustained by donor livers during cold storage prior to transplantation, as has been similarly proposed for the heart, and kidney.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19444967     DOI: 10.1016/j.cryobiol.2009.01.002

Source DB:  PubMed          Journal:  Cryobiology        ISSN: 0011-2240            Impact factor:   2.487


  13 in total

1.  Heme oxygenase system in hepatic ischemia-reperfusion injury.

Authors:  James A Richards; Stephen J Wigmore; Luke R Devey
Journal:  World J Gastroenterol       Date:  2010-12-28       Impact factor: 5.742

Review 2.  Use of carbon monoxide in minimizing ischemia/reperfusion injury in transplantation.

Authors:  Kikumi S Ozaki; Shoko Kimura; Noriko Murase
Journal:  Transplant Rev (Orlando)       Date:  2011-10-13       Impact factor: 3.943

3.  Organ Preservation: Current Concepts and New Strategies for the Next Decade.

Authors:  Edgardo E Guibert; Alexander Y Petrenko; Cecilia L Balaban; Alexander Y Somov; Joaquín V Rodriguez; Barry J Fuller
Journal:  Transfus Med Hemother       Date:  2011-03-21       Impact factor: 3.747

Review 4.  The therapeutic potential of carbon monoxide.

Authors:  Roberto Motterlini; Leo E Otterbein
Journal:  Nat Rev Drug Discov       Date:  2010-09       Impact factor: 84.694

Review 5.  The social network of carbon monoxide in medicine.

Authors:  Barbara Wegiel; Douglas W Hanto; Leo E Otterbein
Journal:  Trends Mol Med       Date:  2012-11-08       Impact factor: 11.951

6.  Carbon Monoxide-Releasing Molecule-3 Alleviates Kupffer Cell Pyroptosis Induced by Hemorrhagic Shock and Resuscitation via sGC-cGMP Signal Pathway.

Authors:  Xu-Peng Wang; Wei-Chao Zheng; Yang Bai; Yan Li; Yue Xin; Jing-Zhou Wang; Yu-Lin Chang; Li-Min Zhang
Journal:  Inflammation       Date:  2021-02-11       Impact factor: 4.092

7.  The immunomodulatory role of carbon monoxide during transplantation.

Authors:  Mariane Tami Amano; Niels Olsen Saraiva Camara
Journal:  Med Gas Res       Date:  2013-01-07

8.  Luminal Administration of a Water-soluble Carbon Monoxide-releasing Molecule (CORM-3) Mitigates Ischemia/Reperfusion Injury in Rats Following Intestinal Transplantation.

Authors:  Takafumi Obara; Hirotsugu Yamamoto; Toshiyuki Aokage; Takuro Igawa; Tsuyoshi Nojima; Takahiro Hirayama; Mizuki Seya; Michiko Ishikawa-Aoyama; Atsunori Nakao; Roberto Motterlini; Hiromichi Naito
Journal:  Transplantation       Date:  2021-12-27       Impact factor: 5.385

9.  A novel hypothermic machine perfusion system using a LifePort Kidney Transporter for the preservation of rat liver.

Authors:  Cheng Zeng; Xiaoyan Hu; Yanfeng Wang; Xianpeng Zeng; Yan Xiong; Ling Li; Qifa Ye
Journal:  Exp Ther Med       Date:  2017-12-01       Impact factor: 2.447

10.  Norborn-2-en-7-ones as physiologically-triggered carbon monoxide-releasing prodrugs.

Authors:  Jui Thiang Brian Kueh; Nathan J Stanley; Russell J Hewitt; Laura M Woods; Lesley Larsen; Joanne C Harrison; David Rennison; Margaret A Brimble; Ivan A Sammut; David S Larsen
Journal:  Chem Sci       Date:  2017-05-30       Impact factor: 9.825

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.